DDL and Gateway Analytical Announce Joint Agreement
EDEN PRAIRIE, MN (PRWEB) SEPTEMBER 18, 2017...
Gateway Analytical to Present on Formulation Development and Establishing Bioequivalence in Drug Products
Gateway Analytical announced today that they...
Gateway Analytical Promotes Expertise in Foreign Particulate Testing Services at the 2016 PDA Universe of Pre-filled Syringes and Injection Devices Conference
Gateway Analytical will exhibit at the...
Gateway Analytical Achieves the Prestigious ASCLD/LAB-International Accreditation for Forensic Trace Evidence Testing!
We are now one (1) of...
Gateway Analytical to Promote Particulate Identification Services at Analytical Symposium and Expo
Gateway Analytical announced today that they...
Gateway Analytical Features Services for Orally Inhaled Drug Products at the Respiratory Drug Delivery Conference in Phoenix
PITTSBURGH, April 6, 2016 — Gateway...
2017 DDL Dual Automated Approach for Sizing and Characterizing Budesonide In Suspension
Authors & ContributorsDavid ExlineEmily Landsperger December 19, 2017 Budesonide is a corticosteroid that is commonly administered by means of a nebulizer to help prevent symptoms of asthma, when regularly inhaled. The suspension contains the ingredients micronized budesonide (API), citric acid, edetate disodium dehydrate, polysorbate 80, sodium chloride, sodium citrate and…
Gateway Analytical and Chemic Laboratories Announce Joint Cooperation Agreement
PITTSBURGH, November 18, 2015 — Chemic...
Gateway Analytical Registers with U.S. Food and Drug Administration
Gateway Analytical showed confidence in its...
Gateway Analytical to Present on the Evolution of Gunshot Residue Analysis at the IACP 121st Annual Conference and Exposition
Gateway Analytical announced today that they...